TMCI Insider Trading
Insider Ownership Percentage: 24.43%
Insider Buying (Last 12 Months): $4,206,561.76
Insider Selling (Last 12 Months): $398,500.00
Treace Medical Concepts Insider Trading History Chart
This chart shows the insider buying and selling history at Treace Medical Concepts by year and by quarter.
Skip ChartChart Data in Insider Trading History Table
Treace Medical Concepts Share Price & Price History
Current Price: $7.41
Price Change: ▲ Price Increase of +0.31 (4.37%)
As of 04/9/2025 05:00 PM ET
Treace Medical Concepts Insider Trading History
SEC Filings (Institutional Ownership Changes) for Treace Medical Concepts (NASDAQ:TMCI)
84.08% of Treace Medical Concepts stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.
Institutional Buying and Selling by Quarter
This chart shows the instiutional buying and selling at TMCI by year and by quarter.
Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
Treace Medical Concepts Institutional Trading History
Data available starting January 2016
Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to surgically correct three planes of the bunion deformity. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision. In addition, the company offers Adductoplasty system designed for reproducible realignment, stabilization, and fusion of the midfoot. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.
Read More on Treace Medical Concepts
Volume
622,119 shs
Average Volume
748,148 shs
Market Capitalization
$464.01 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.77
Who are the company insiders with the largest holdings of Treace Medical Concepts?
Who are the major institutional investors of Treace Medical Concepts?
Which institutional investors are buying Treace Medical Concepts stock?
Within the previous quarter, TMCI stock was bought by institutional investors including:
- GAMMA Investing LLC
- Rhumbline Advisers
Within the previous year, these company insiders have bought Treace Medical Concepts stock:
- John T Treace (CEO)
- James T Treace (Director)
- F Barry Bays (Director)
- Richard W Mott (Director)
Learn More investors buying Treace Medical Concepts stock.